L-Asparaginsaeure
Brand names,
L-Asparaginsaeure
Analogs
L-Asparaginsaeure
Brand Names Mixture
L-Asparaginsaeure
Chemical_Formula
C4H7N1O4
L-Asparaginsaeure
RX_link
No information avaliable
L-Asparaginsaeure
fda sheet
L-Asparaginsaeure
msds (material safety sheet)
L-Asparaginsaeure
Synthesis Reference
No information avaliable
L-Asparaginsaeure
Molecular Weight
133.104 g/mol
L-Asparaginsaeure
Melting Point
230 oC
L-Asparaginsaeure
H2O Solubility
4.5 g/l
L-Asparaginsaeure
State
Solid
L-Asparaginsaeure
LogP
-0.67 +/- 0.36
L-Asparaginsaeure
Dosage Forms
Capsules and powder
L-Asparaginsaeure
Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
L-Asparaginsaeure
Pharmacology
L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.
L-Asparaginsaeure
Absorption
Absorbed from the small intestine by an active transport process
L-Asparaginsaeure
side effects and Toxicity
Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.
L-Asparaginsaeure
Patient Information
No information avaliable
L-Asparaginsaeure
Organisms Affected
Humans and other mammals